Dr Mohammad Raza Anees, MBBS | |
3300 Oakdale Ave N, Robbinsdale, MN 55422-2926 | |
(763) 520-5200 | |
Not Available |
Full Name | Dr Mohammad Raza Anees |
---|---|
Gender | Male |
Speciality | Internal Medicine - Gastroenterology |
Location | 3300 Oakdale Ave N, Robbinsdale, Minnesota |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124137104 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | L#14742R (Louisiana) | Secondary |
207RG0100X | Internal Medicine - Gastroenterology | 60383 (Minnesota) | Primary |
Entity Name | Mch Professional Care |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649391269 PECOS PAC ID: 1658358635 Enrollment ID: O20040707001020 |
News Archive
In a paper recently published in Diabetes Care, Saint Louis University associate professor of nutrition and dietetics Edward Weiss, Ph.D, and colleagues found that, though people often think of the benefits from exercise, calorie restriction and weight loss as interchangeable, it appears that they may all offer distinct and cumulative benefits when it comes to managing Type 2 diabetes risk.
A team of Australian doctors have identified a new disease and its cure. In their report published in the journal Clinical Infectious Diseases the doctors from The Queensland Institute of Medical Research (QIMR) report a case of a young NSW woman ill for almost a decade with repeated hospitalizations. She is now said to be suffering from a diseases that disabled the signaling processes of her immune system. The diseases is not named yet. Dr Maher Gandhi, head of QIMR's Immunohemotology Laboratory believes there are more cases of this disease. He said this Monday, "I haven't got a name for it other than T-cell signaling defect of which I assume there are quite a few different types… There are no recorded cases of this in the literature. Katie is unique ... I think we're at the tip of the iceberg here."
Rep. Fred Upton (R-Mich.), chairman-in-waiting of the powerful Energy and Commerce Committee, announced on Thursday the chairmen and vice-chairmen on his committee. As predicted, abortion-rights foe Rep. Joe Pitts (R-Pa.) got the chairmanship of the health subcommittee in a sop to conservatives who bitterly opposed Upton because he has not supported efforts to enact parental notification laws, to defund embryonic stem cell research or oppose "partial-birth" abortion.
Researchers at the University of California, San Diego School of Medicine have identified a microRNA molecule as a surprisingly crucial player in managing cell survival and growth.
BIND Biosciences announced today that it has initiated a Phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of BIND-014 in cancer patients. BIND-014, the first product candidate to enter clinical evaluation from BIND's broad proprietary Medicinal Nanoengineering platform, is a targeted polymeric nanoparticle containing the cytotoxic agent, docetaxel.
› Verified 5 days ago
Entity Name | Healthtexas Provider Network |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
In a paper recently published in Diabetes Care, Saint Louis University associate professor of nutrition and dietetics Edward Weiss, Ph.D, and colleagues found that, though people often think of the benefits from exercise, calorie restriction and weight loss as interchangeable, it appears that they may all offer distinct and cumulative benefits when it comes to managing Type 2 diabetes risk.
A team of Australian doctors have identified a new disease and its cure. In their report published in the journal Clinical Infectious Diseases the doctors from The Queensland Institute of Medical Research (QIMR) report a case of a young NSW woman ill for almost a decade with repeated hospitalizations. She is now said to be suffering from a diseases that disabled the signaling processes of her immune system. The diseases is not named yet. Dr Maher Gandhi, head of QIMR's Immunohemotology Laboratory believes there are more cases of this disease. He said this Monday, "I haven't got a name for it other than T-cell signaling defect of which I assume there are quite a few different types… There are no recorded cases of this in the literature. Katie is unique ... I think we're at the tip of the iceberg here."
Rep. Fred Upton (R-Mich.), chairman-in-waiting of the powerful Energy and Commerce Committee, announced on Thursday the chairmen and vice-chairmen on his committee. As predicted, abortion-rights foe Rep. Joe Pitts (R-Pa.) got the chairmanship of the health subcommittee in a sop to conservatives who bitterly opposed Upton because he has not supported efforts to enact parental notification laws, to defund embryonic stem cell research or oppose "partial-birth" abortion.
Researchers at the University of California, San Diego School of Medicine have identified a microRNA molecule as a surprisingly crucial player in managing cell survival and growth.
BIND Biosciences announced today that it has initiated a Phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of BIND-014 in cancer patients. BIND-014, the first product candidate to enter clinical evaluation from BIND's broad proprietary Medicinal Nanoengineering platform, is a targeted polymeric nanoparticle containing the cytotoxic agent, docetaxel.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Mohammad Raza Anees, MBBS 3300 Oakdale Ave N, Robbinsdale, MN 55422-2926 Ph: (763) 520-5200 | Dr Mohammad Raza Anees, MBBS 3300 Oakdale Ave N, Robbinsdale, MN 55422-2926 Ph: (763) 520-5200 |
News Archive
In a paper recently published in Diabetes Care, Saint Louis University associate professor of nutrition and dietetics Edward Weiss, Ph.D, and colleagues found that, though people often think of the benefits from exercise, calorie restriction and weight loss as interchangeable, it appears that they may all offer distinct and cumulative benefits when it comes to managing Type 2 diabetes risk.
A team of Australian doctors have identified a new disease and its cure. In their report published in the journal Clinical Infectious Diseases the doctors from The Queensland Institute of Medical Research (QIMR) report a case of a young NSW woman ill for almost a decade with repeated hospitalizations. She is now said to be suffering from a diseases that disabled the signaling processes of her immune system. The diseases is not named yet. Dr Maher Gandhi, head of QIMR's Immunohemotology Laboratory believes there are more cases of this disease. He said this Monday, "I haven't got a name for it other than T-cell signaling defect of which I assume there are quite a few different types… There are no recorded cases of this in the literature. Katie is unique ... I think we're at the tip of the iceberg here."
Rep. Fred Upton (R-Mich.), chairman-in-waiting of the powerful Energy and Commerce Committee, announced on Thursday the chairmen and vice-chairmen on his committee. As predicted, abortion-rights foe Rep. Joe Pitts (R-Pa.) got the chairmanship of the health subcommittee in a sop to conservatives who bitterly opposed Upton because he has not supported efforts to enact parental notification laws, to defund embryonic stem cell research or oppose "partial-birth" abortion.
Researchers at the University of California, San Diego School of Medicine have identified a microRNA molecule as a surprisingly crucial player in managing cell survival and growth.
BIND Biosciences announced today that it has initiated a Phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of BIND-014 in cancer patients. BIND-014, the first product candidate to enter clinical evaluation from BIND's broad proprietary Medicinal Nanoengineering platform, is a targeted polymeric nanoparticle containing the cytotoxic agent, docetaxel.
› Verified 5 days ago
Dr. Alok Maheshwari, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3300 Oakdale Ave N, Robbinsdale, MN 55422 Phone: 763-581-5400 Fax: 763-581-5401 | |
Hani Al Salti Al Krad, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3300 Oakdale Ave N, Robbinsdale, MN 55422 Phone: 763-520-5200 | |
Ethan Michael Fruechte, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3300 Oakdale Ave N, Suite 200, Robbinsdale, MN 55422 Phone: 763-581-5400 Fax: 763-520-2099 | |
Matthew Nolan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3366 Oakdale Ave N Ste 401, Robbinsdale, MN 55422 Phone: 763-520-2940 | |
Jerrold Martin Stempel, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3366 Oakdale Ave N, Suite 315, Robbinsdale, MN 55422 Phone: 763-520-7900 Fax: 763-520-7989 | |
Chike Uchenna Anthony Obi, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3300 Oakdale Ave N, Robbinsdale, MN 55422 Phone: 763-581-5400 Fax: 763-581-5401 | |
Dr. John Manion, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3435 West Broadway, Suite 1065, Robbinsdale, MN 55422 Phone: 763-520-1137 Fax: 763-520-1976 |